Juventas Cell Therapy Ltd.

This early-phase study is testing the safety and initial effectiveness of an experimental cell therapy called CNCT19 injection for people with severe, relapsing autoimmune diseases that attack the brain and nerves. It will enroll 18 adults whose conditions—like multiple sclerosis…